Preclinical Pharmacokinetic and Pharmacology Evaluations of Agents Being Developed for Cancer Patients
Awarded on September 24, 2021. Full description on SAM.gov.
Overview
- Posted
- September 28, 2021
- Notice type
- Award Notice
- NAICS
- 541715: Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
- Agency
- Department of Health and Human ServicesNATIONAL INSTITUTES OF HEALTH
Notice details
- Office
- NIH National Cancer Institute
- Last updated
- Dec 4, 2025
- Award date
- Sep 24, 2021
- Award amount (SAM.gov award notice)
- $9.9M
Identifiers
- Solicitation number
- 75N91021R00007
- Notice ID
- 4a528d54ab494b4da543048b5d0229bc
- Award number (PIID)
- Multiple_Contracts-See_Below
Description
Award Overview
Award Number
Multiple_Contracts-See_Below
Award Amount (SAM.gov award notice)
$9.9M
Award Date
Sep 24, 2021
Awardee
Original Solicitation
Notice ID: 4a528d54ab494b4da543048b5d0229bc
Posted Date: Sep 28, 2021
Original Response Deadline: Not specified
Contract Details
Contract data not yet available
Contract details typically appear within 2-4 weeks after award; DoD awards are published about 90 days after signature.
Contacts
Documents
No documents available.
Lifecycle
75N91021R00007- Pre-Solicitation
- Solicitation
- Awarded
This opportunity has been awarded.
- Pre-SolicitationOct 28, 2020
Preclinical Pharmacokinetic and Pharmacology Evaluations of Agents Being Developed for Cancer Patients
- 5×SolicitationNov 20, 2020
Preclinical Pharmacokinetic and Pharmacology Evaluations of Agents Being Developed for Cancer Patients
- AwardedCurrentSep 28, 2021
Preclinical Pharmacokinetic and Pharmacology Evaluations of Agents Being Developed for Cancer Patients
Similar Opportunities
Title | Match | Phase | Deadline |
|---|---|---|---|
Additional Details
Solicitation Number
75N91021R00007
Archive Date
Oct 9, 2021
Office Address
Rockville, MD, 20850